The FDA’s Decision to Pause J&J Could Help Defeat Covid-19

dc.contributor.authorMcLaren, Zoe
dc.date.accessioned2021-12-03T16:57:33Z
dc.date.available2021-12-03T16:57:33Z
dc.date.issued2021-04-16
dc.descriptionPhotographer: Michael Ciagloen
dc.description.urihttps://www.wired.com/story/fda-decision-pause-jandj-could-help-defeat-covid/en
dc.genrearticlesen
dc.identifierdoi:10.13016/m2rj4a-tsps
dc.identifier.citationMcLaren, Zoe; The FDA’s Decision to Pause J&J Could Help Defeat Covid-19; Ideas, 16 April, 2021; https://www.wired.com/story/fda-decision-pause-jandj-could-help-defeat-covid/en
dc.identifier.urihttp://hdl.handle.net/11603/23516
dc.language.isoenen
dc.publisherWireden
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC School of Public Policy Collection
dc.relation.ispartofUMBC Faculty Collection
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.en
dc.subjectJohnson & Johnson’s Covid-19 vaccineen
dc.subjectvaccine hesitancyen
dc.subjectFood and Drug Administrationen
dc.titleThe FDA’s Decision to Pause J&J Could Help Defeat Covid-19en
dc.typeTexten
dcterms.creatorhttps://orcid.org/0000-0003-2515-9731en

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description: